Immunocore’s flotation in the US has raised $258 million.   The pricing of its initial public offering on the Nasdaq in New York, managed by investment banks Goldman Sachs, JP Morgan … Continue reading UK BioTech Immunocore raises $273m as it launches upsized US flotation